Sensitivity of l-(-)2′,3′-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues
Open Access
- 15 June 1999
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 57 (12) , 1351-1359
- https://doi.org/10.1016/s0006-2952(99)00073-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Transient Selection of A Hepatitis B Virus Polymerase Gene Mutant Associated With A Decreased Replication Capacity and Famciclovir ResistanceHepatology, 1999
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998
- Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapyHepatology, 1998
- Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudineLiver International, 1997
- Inhibition of Hepatitis B Virus Dna Polymerase by Enantiomers of Penciclovir Triphosphate and Metabolic Basis for Selective Inhibition of Hbv Replication by PenciclovirHepatology, 1996
- Selection of Mutations in the Hepatitis B Virus Polymerase During Therapy of Transplant Recipients With LamivudineHepatology, 1996
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Long-Term Efficacy Of Active Postexposure Immunization Of Infants For Prevention Of Hepatitis B Virus InfectionThe Journal of Infectious Diseases, 1995
- Effects of purine nucleoside analogues with a cyclobutane ring and erythromycin A oxime derivatives on duck hepatitis B virus replication in vivo and in cell culture and HIV-1 in cell cultureJournal of Medical Virology, 1991
- HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUSThe Lancet, 1981